{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T17:39:04Z","timestamp":1760204344462},"reference-count":29,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2008,10,29]],"date-time":"2008-10-29T00:00:00Z","timestamp":1225238400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Congenital Anomalies"],"published-print":{"date-parts":[[2008,12]]},"abstract":"<jats:p><jats:bold>ABSTRACT\u2003<\/jats:bold> Exposure to polychlorobiphenyl (PCB) mixtures at an early stage of development has been reported to affect endocrine glands; however, little is known about the precise toxicological properties of individual PCB. The present study was undertaken to determine whether prenatal exposure to 2,2\u2032,4,4\u2032,5,5\u2032\u2010hexachlorobiphenyl (PCB 153), a di\u2010<jats:italic>ortho<\/jats:italic>\u2010substituted non\u2010coplanar congener, affects postnatal development in rat offspring. Pregnant Sprague\u2010Dawley rats (Crj: CD (SD) IGS) were given PCB 153 (0, 16, or 64\u2003mg\/kg\/day) orally from gestational day (GD) 10 through GD 16, and developmental parameters in the male and female offspring were examined. We found no dose\u2010dependent changes in body weight, body length (nose\u2013anus length), tail length, or the weights of kidneys, testes, ovaries and uterus in offspring at 1 or 3\u2003weeks of age. Liver weights were increased in the PCB 153\u2013treated groups, although we observed a significant difference only in males. Anogenital distance was unaffected in the PCB 153\u2013treated groups. We observed a significant dose\u2010dependent decrease in the plasma concentrations of thyroxine and tri\u2010iodothyronine, whereas those of thyroid\u2010stimulating hormone were not significantly changed. In addition, there were no dose\u2010dependent changes in plasma concentrations of growth hormone and insulin\u2010like growth factor\u2010I in any dose group. These findings suggest that prenatal exposure to PCB 153 (GD 10\u201316, 16\u201364\u2003mg\/kg\/day) may alter the thyroid status in rat offspring to some extent without affecting somatic growth or its related hormonal parameters.<\/jats:p>","DOI":"10.1111\/j.1741-4520.2008.00199.x","type":"journal-article","created":{"date-parts":[[2009,2,17]],"date-time":"2009-02-17T03:52:02Z","timestamp":1234842722000},"page":"151-157","source":"Crossref","is-referenced-by-count":17,"title":["Effects of <i>in utero<\/i> exposure to 2,2\u2032,4,4\u2032,5,5\u2032\u2010hexachlorobiphenyl (PCB 153) on somatic growth and endocrine status in rat offspring"],"prefix":"10.1111","volume":"48","author":[{"given":"Kenichi","family":"Kobayashi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muneyuki","family":"Miyagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui\u2010Sheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Megumi","family":"Suda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soichiro","family":"Sekiguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Honma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,10,29]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1080\/152873901753215948"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1093\/toxsci\/kfg248"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1289\/ehp.99107273"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1099-1263(199603)16:2<121::AID-JAT320>3.0.CO;2-G"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(95)02087-X"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0890-6238(99)00036-2"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1289\/ehp.6672"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1006\/taap.1995.1210"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tox.2004.11.037"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1043-2760(00)00238-1"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1203\/00006450-199410000-00009"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1098-2795(199910)54:2<126::AID-MRD4>3.0.CO;2-B"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1289\/ehp.94102290"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1006\/taap.1993.1168"},{"key":"e_1_2_6_16_1","first-page":"4","article-title":"NTP technical report on the toxicology and carcinogenesis studies of 2,2\u2032,4,4\u2032,5,5\u2032\u2010hexachlorobiphenyl (PCB 153) (CAS No. 35065\u201027\u20101) in female Harlan Sprague\u2010Dawley rats (Gavage studies)","volume":"529","author":"National Toxicology Program","year":"2006","journal-title":"Natl Toxicol Program Tech Rep Ser"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/0378-4274(93)90023-Q"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1210\/er.19.1.55"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1210\/er.18.4.462"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1530\/rep.1.00690"},{"key":"e_1_2_6_21_1","first-page":"94","article-title":"The role of thyroid hormones in prenatal and neonatal neurological development \u2013 current perspectives","volume":"14","author":"Porterfield SP","year":"1993","journal-title":"Endocr Rev"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.3109\/10408449409049308"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1177\/096032719401301213"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1006\/faat.1995.1081"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/0378-4274(95)03329-J"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1210\/en.2007-1431"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/0269-7491(88)90183-2"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1289\/ehp.7253"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.pharmtox.39.1.103"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1210\/endo.141.1.7273"}],"container-title":["Congenital Anomalies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1741-4520.2008.00199.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1741-4520.2008.00199.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T14:00:33Z","timestamp":1697378433000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1741-4520.2008.00199.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10,29]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["10.1111\/j.1741-4520.2008.00199.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1741-4520.2008.00199.x","archive":["Portico"],"relation":{},"ISSN":["0914-3505","1741-4520"],"issn-type":[{"value":"0914-3505","type":"print"},{"value":"1741-4520","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,10,29]]}}}